相关实验视频
Updated: Jul 9, 2025

04:23
Application of Hemostatic Devices in Laparoscopic Hepatectomy
Published on: April 19, 2022
2.2K
如何在干预期间管理肝病患者的血液静止
1King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, Denmark Hill, London, SE5 9RS.
Hematology. American Society of Hematology. Education Program
|December 9, 2023
概括
患有慢性肝病 (CLD) 的患者接受手术时,不应根据异常的静血检测进行常规输血,因为这些标志物无法预测出血风险. 避免不必要的输血,以控制CLD患者的出血风险.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 血液学 血液学 血液学
- 干预医学是干预的医学.
背景情况:
- 晚期慢性肝病 (CLD) 患者经常需要进行门脉压并发症的手术,如炎或胃肠道出血.
- 血液静止测试 (例如,延长PT/INR,血小板减少) 在CLD中经常异常,引发了人们对出血风险的担忧.
- 目前的做法可能涉及输血,以纠正这些异常干预之前.
研究的目的:
- 审查患有CLD的患者的静血管理.
- 评估血液静止异常常规纠正的实用性.
- 为适当的输血策略提供指导.
主要方法:
- 这是一个叙事评论.
- 这篇评论讨论了CLD中的静血管理.
- 案例描述用于说明关键点.
主要成果:
- 异常的静血检测结果在CLD患者中很常见.
- 这些静血标记是实际出血风险的不良预测指标.
- 通常不建议对静血异常进行常规纠正.
结论:
- 在CLD中,应个性化进行静血管理.
- 避免仅基于异常检测结果进行常规输血 (例如新鲜冷血,血小板).
- 专注于门高血压和相关出血风险的适当管理策略.
相关概念视频
Esophageal Varices-II: Clinical Features and Management
71
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
71
Disorders of Hemostasis
922
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
922
Anticoagulant Drugs: Low-Molecular-Weight Heparins
708
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
708
Introduction to Hemostasis
8.0K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
8.0K
Extrinsic and Intrinsic Pathways of Hemostasis
7.9K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.9K
Esophageal Varices-I: Introduction
149
Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
149

